Interim Clinical Data Expected News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Interim Clinical Data Expected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Interim Clinical Data Expected Today - Breaking & Trending Today

Aeglea BioTherapeutics Announces Leadership Transition and Corporate Restructuring

Published: August 24, 2022

/PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as...

Source: prnewswire.com

Related Topics:

United StatesJim KastenmayerAeglea BiotherapeuticsMichael HanleyRussellj CoxAnthony QuinnPrnewswire Aeglea Biotherapeutics IncPrioritizing ResourcesOngoing PhaseInterim Clinical Data ExpectedBoard MemberStepped DownHis Current PositionsExtend RunwayClassical HomocystinuriaDrug DesignationPediatric DiseaseRare Pediatric DiseaseBreakthrough Therapy